Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

Study overview

The objective of this randomized, controlled pilot study is to determine the efficacy of Deferiprone to reduce the amount of free iron inside the hemorrhagic zone of myocardial infarction among hemorrhagic myocardial infarction patients.

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Collaborators and Investigators

Rohan Dharmakumar,

Rohan Dharmakumar, PhD, PRINCIPAL_INVESTIGATOR, Krannert Cardiovascular Research Center

Keyur P Vora, MD FACP FACC, PRINCIPAL_INVESTIGATOR, Krannert Cardiovascular Research Center

Study Record Dates

2025-07-01